Dashboard
Manage Tickers

SAVACASSAVA SCIENCES INC

Nasdaq cassavasciences.com


$ 20.24 $ -0.88 (-4.17 %)    

Friday, 10-May-2024 15:59:16 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 441.71 $ 1.04 (0.24 %)
DIA $ 395.04 $ 1.18 (0.3 %)
SPY $ 520.76 $ 0.67 (0.13 %)
TLT $ 90.14 $ -0.51 (-0.56 %)
GLD $ 218.73 $ 1.76 (0.81 %)
$ 20.23
$ 21.10
$ 0.00 x 0
$ 20.25 x 100
$ 20.04 - $ 21.10
$ 12.32 - $ 32.10
608,558
na
892.18M
$ 1.24
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-10-2024 03-31-2024 10-Q
2 02-28-2024 12-31-2023 10-K
3 11-07-2023 09-30-2023 10-Q
4 08-03-2023 06-30-2023 10-Q
5 05-01-2023 03-31-2023 10-Q
6 02-28-2023 12-31-2022 10-K
7 11-07-2022 09-30-2022 10-Q
8 08-04-2022 06-30-2022 10-Q
9 05-05-2022 03-31-2022 10-Q
10 02-28-2022 12-31-2021 10-K
11 11-15-2021 09-30-2021 10-Q
12 08-04-2021 06-30-2021 10-Q
13 04-29-2021 03-31-2021 10-Q
14 03-23-2021 12-31-2020 10-K
15 11-09-2020 09-30-2020 10-Q
16 08-12-2020 06-30-2020 10-Q
17 05-06-2020 03-31-2020 10-Q
18 03-26-2020 12-31-2019 10-K
19 10-29-2019 09-30-2019 10-Q
20 08-12-2019 06-30-2019 10-Q
21 05-02-2019 03-31-2019 10-Q
22 03-29-2019 12-31-2018 10-K
23 10-30-2018 09-30-2018 10-Q
24 07-26-2018 06-30-2018 10-Q
25 05-09-2018 03-31-2018 10-Q
26 02-06-2018 12-31-2017 10-K
27 11-01-2017 09-30-2017 10-Q
28 08-09-2017 06-30-2017 10-Q
29 04-26-2017 03-31-2017 10-Q
30 03-07-2017 12-31-2016 10-K
31 10-26-2016 09-30-2016 10-Q
32 07-19-2016 06-30-2016 10-Q
33 05-05-2016 03-31-2016 10-Q
34 03-03-2016 12-31-2015 10-K
35 11-09-2015 09-30-2015 10-Q
36 07-23-2015 06-30-2015 10-Q
37 05-08-2015 03-31-2015 10-Q
38 02-18-2015 12-31-2014 10-K
39 11-05-2014 09-30-2014 10-Q
40 08-06-2014 06-30-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

cassava-sciences-reports-clinical-updates-on-phase-3-trials-of-simufilam
Cassava Sciences Reports Clinical Updates ...
05/10/2024 20:04:57

Current Updates on Phase 3 Clinical ProgramBackground - Our Phase 3 program consists of two global, double-blind, randomized, p...

cassava-sciences-q1-eps-043-beats-046-estimate
Cassava Sciences Q1 EPS $(0.43) Beats $(0....
05/10/2024 20:02:40

Cassava Sciences (NASDAQ:SAVA) reported quarterly losses of $(0.43) per share which beat the analyst consensus estimate of $(0....

cassava-sciences-says-proceeds-warrant-distribution-represents-sale-of-57m-shares-at-22share
Cassava Sciences Says Proceeds Warrant Dis...
05/08/2024 15:03:30

cassava-sciences-secures-over-125m-from-warrant-distribution
Cassava Sciences Secures Over $125M From W...
05/08/2024 15:01:45

cassava-sciences-reports-125m-from-warrant-distribution
Cassava Sciences Reports $125M From Warran...
05/08/2024 15:01:08

why-jpmorgan-shares-are-trading-lower-by-around-5-here-are-other-stocks-moving-in-fridays-mid-day-session
Why JPMorgan Shares Are Trading Lower By A...
04/12/2024 18:47:23

Shares of JPMorgan Chase & Co. (NYSE: JPM) fell sharply during Friday’s session following first-quarter earnings.

cassava-sciences-completes-interim-safety-review-of-oral-simufilam-on-going-phase-3-trials
Cassava Sciences Completes Interim Safety ...
03/25/2024 13:14:02

An Independent Data and Safety Monitoring Board (DSMB) Recently Evaluated the Interim Patient Safety Database for Oral Simufila...

sava---analyzing-cassava-sciencess-short-interest
(SAVA) - Analyzing Cassava Sciences's Shor...
03/21/2024 16:30:14

alzheimers-drug-trial-results-questioned-after-damning-fda-inspection-report
Alzheimer's Drug Trial Results Questioned ...
03/12/2024 03:51:43

The credibility of the clinical trial results for an experimental Alzheimer's drug has been called into question following ...

boeing-oracle-meta-platforms-cassava-sciences-tesla-why-these-5-stocks-are-on-investors-radars-today
Boeing, Oracle, Meta Platforms, Cassava Sc...
03/12/2024 02:33:37

On Monday, the U.S. stock market presented a mixed performance. The Dow Jones index managed to turn higher, trading up by 0.12%...

hc-wainwright--co-reiterates-buy-on-cassava-sciences-maintains-124-price-target
HC Wainwright & Co. Reiterates Buy on Cass...
03/05/2024 11:43:17

HC Wainwright & Co. analyst Vernon Bernardino reiterates Cassava Sciences (NASDAQ:SAVA) with a Buy and maintains $124 pr...

cassava-sciences-q4-earnings-insights
Cassava Sciences: Q4 Earnings Insights
02/28/2024 21:00:08

cassava-sciences-q4-eps-050-beats-052-estimate
Cassava Sciences Q4 EPS $(0.50) Beats $(0....
02/28/2024 14:18:11

Cassava Sciences (NASDAQ:SAVA) reported quarterly losses of $(0.50) per share which beat the analyst consensus estimate of $(0....

why-alzheimers-drug-developer-cassava-sciences-stock-is-trending
Why Alzheimers-Drug Developer Cassava Scie...
02/07/2024 16:15:25

The top-line results showed no decline in cognition scores in patients with mild Alzheimer's disease who received simufilam...

cassava-sciences-reports-top-line-results-of-two-year-clinical-safety-study-of-simufilam-investigational-oral-drug-for-treatment-of-alzheimers-disease
Cassava Sciences Reports Top-Line Results ...
02/07/2024 14:18:04

ADAS-Cog Scores Were Stable in a Group of Patients with Mild Alzheimer's Who Received Drug Candidate Simufilam Continuously...

sava---analyzing-cassava-sciencess-short-interest
(SAVA) - Analyzing Cassava Sciences's Shor...
01/29/2024 15:15:16

10-health-care-stocks-with-whale-alerts-in-todays-session
10 Health Care Stocks With Whale Alerts In...
01/15/2024 17:35:18

cassava-sciences-announced-that-it-will-distribute-warrants-to-purchase-shares-of-common-stock-to-its-shareholders-on-jan-3-2024-with-each-shareholder-receiving-four-warrants-for-every-ten-shares-of-common-stock-they-hold
Cassava Sciences Announced That It Will Di...
01/03/2024 14:21:19

https://www.sec.gov/ix?doc=/Archives/edgar/data/1069530/000149315224000209/form8-k.htm

why-carmax-shares-are-trading-higher-by-around-8-here-are-other-stocks-moving-in-thursdays-mid-day-session
Why CarMax Shares Are Trading Higher By Ar...
12/21/2023 18:01:44

Shares of CarMax, Inc. (NYSE: KMX) moved higher during Thursday’s session following better-than-expected quarterly earnings.

paychex-reports-downbeat-sales-joins-blackberry-and-other-big-stocks-moving-lower-on-thursday
Paychex Reports Downbeat Sales, Joins Blac...
12/21/2023 16:02:00

U.S. stocks traded higher, with the Dow Jones index gaining around 200 points on Thursday.

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION